TOOLS & RESOURCES

Product Advisories

IMPORTANT PRODUCT INFORMATION

We pursue excellence in every product we make. We have a strong history of product safety and reliability, and we remain dedicated to developing technology and products that save and improve the lives of patients worldwide.

We take our responsibilities as a leading device manufacturer very seriously and recognize our primary responsibility is to ensure that our devices are of the highest quality and function safely and properly.

Our commitment to business integrity means we quickly share with professionals and patients the important information they need about our products’ performance and safety. These product advisories and communications remain available for review.
 

Update to Important Information Regarding SVD in Trifecta Family of Valves – July, 2023

An update was issued to the February 2023 communication for the Trifecta family of valves. This communication is to inform customers that Abbott is initiating a US Market Withdrawal for the Trifecta family of valves and will be removing the limited remaining inventory from the field. Additional educational information on long term care and SVD for patients implanted with Trifecta family of valves is available here.

Customer Letter

 

Medical Device Recall: Amplatzer™ Steerable Delivery Sheath – June, 2023

A recall notification was issued to customers in June 2023 due to the potential for air embolism specific to the hemostasis valve of the Amplatzer™ Steerable Delivery Sheath.

PHYSICIAN COMMUNICATION

 

Important Information Regarding SVD in Trifecta Family of Valves – February, 2023

Abbott is providing information regarding Structural Valve Deterioration (SVD) related to its Trifecta family of bioprosthetic heart valves. This communication is intended to raise awareness regarding the potential for early SVD and provide patient management considerations.

CUSTOMER LETTER

 

Medical Device Correction: MitraClip Delivery System – September, 2022

Abbott is sharing information about the use of the MitraClip Delivery System. Abbott has observed an increase in complaints regarding Clip locking malfunctions. This communication is to bring awareness, share the actions Abbott is taking, and emphasize the relevant steps of the Instructions for Use (IFU) to aid in optimal function of the Clip locking mechanism.

PHYSICIAN COMMUNICATION

MAT-2210982 v6.0 | Item approved for U.S. use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

+